Rational basis for Trk inhibition therapy for prostate cancer

Prostate

Volumn 45, Issue 2, 2000, Pages 140-148

  Weeraratna, Ashani T ^a   Arnold, Julia T ^a   George, Dan J ^a   DeMarzo, Angelo ^a,b   Isaacs, John T ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JHMI   (United States)

Author keywords

Androgen independence; Apoptosis; Signal transduction; Survival pathways

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CARBAZOLE DERIVATIVE; CEP 751; INDOLE DERIVATIVE; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; NEUROTROPIN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; RECEPTOR SUBTYPE; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; BINDING AFFINITY; CANCER CELL; CANCER GROWTH; CELL SURVIVAL; CONTROLLED STUDY; ENZYME INHIBITION; HORMONE DEPENDENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PARACRINE SIGNALING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STROMA CELL;

EID: 0033815648     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0045(20001001)45:2<140::aid-pros8>3.0.co;2-%23     Document Type: Article

References (26)

1. Cancer Statistics 2000 CA
2. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma
3. Implications of cell kinetic changes during the progression of human prostate cancer
4. Tyrosine kinase receptor-activated signal transduction pathway which lead to oncogenesis
5. C-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines
6. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF activated phosphatidylinositol 3-kinase
7. Akt signaling: Linking membrane events of life and death decisions
8. Cell cycle-independent death of prostate adenocarcinoma is induced by the trk tyrosine kinase inhibitor CEP-751 (KT6587)
9. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555)
10. Neurotrophin signal transduction by the trk receptor
11. Expression of the trk high affinity nerve growth factor receptor in the human prostate
12. Cellular localization of the trk neurotrophin receptor family in human non-neuronal tissue
13. Signaling through the neurotrophin receptor p75NTR
14. Loss of iowaffinity nerve growth factor receptor during malignant transformation of the human prostate
15. The expression and localization of ct-nerve growth factor (ct-NGF) in benign and malignant human prostate tissue: Relationship to neuroendocrine differentiation
16. A simple method for the isolation and culture of epithelial and stromal cells from benign and neoplastic prostates
17. A new human prostate carcinoma cell line, CWR22Rvl
18. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice
19. Programmed death of nonproliferating androgen-independent prostatic cancer cell
20. CEP-751 inhibits trk receptor kinase activity in vitro and exhibits anti-tumor activity
21. Insulin-like growth factor-(IGF-1) levels in bovine sera
22. Role of androgens in prostatic cancer
23. Dysregulated expression of growth factors and their receptors in the development of prostate cancer
24. Prostate innervation
25. 1-Adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation/n patients with benign prostatic hyperplasia
26. Prostatic stromal cell phenotype is directly modulated by norepinephrine